Skip to main content



On September 30th, we organised the first-ever BAROSTIM THERAPY Summit in Berlin. During this day, thought leaders from across Europe and from the US presented the state-of-the-art on Baroreflex Actviation Therapy and its uses in both resistant hypertension and heart failure. You can find here the presentations that were given that day.

BAROSTIM THERAPY Here & Now: Scientific Updates

Evidence of Baroreflex Activation Therapy’s mechanism of action – Prof. Edoardo Gronda Multimedica, IT

New heart failure RCT: Update on BeAT-HF in the US – Prof. Michael Zile University of South Carolina, US

New hypertension RCT: Update on ESTIM-rHTN in France – Prof. Patrick Rossignol University of Nancy, FR


Hypertension consensuses: The Netherlands & Germany

Prof. Bram Kroon University Maastricht, NL; Prof. Hannes Reuter University Cologne, DE


Best Practices: Treating Hypertension with BAROSTIM THERAPY

What can we do when other therapies fail?:HTN Guidelines – Prof. Markus van der Giet Charité Berlin, DE

Who are the most appropriate hypertension patients for BAROSTIM THERAPY? – Prof. Hannes Reuter niversity Cologne, DE

How do we find these patients?: The experience of Klinikum Tuttlingen – Dr. Michael Kotzerke Klinikum Tuttlingen, DE


Best Practices: Treating Heart Failure with BAROSTIM THERAPY

What can we do after Entresto, ICD, CRT, MitraClip… and before LVAD?: HF Guidelines – Prof. Stefan Anker Charité Berlin, DE

Who are the most appropriate heart failure patients for BAROSTIM THERAPY? – Dr. Joern Schmitt University Giessen, DE

How do we find these patients? The experience of Medical University Hannover – PD Dr. Christian Veltmann Medical University Hannover, DE

Moving Forward, Together

Launching the BAROSTIM NEO Global Registry – Prof. Jochen Mueller-Ehmsen Asklepios Clinic Altona, DE; Prof. Burkert Pieske Charite Berlin, DE

top of page